• Solanesol B8776: Handling and Assay Workflow Guide

  2026-08-19

  Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical workflows, including membrane-related experiments and selected enzyme or cell-based assays. Its limited solvent compatibility means it should be prepared in DMSO, handled as a fresh solution when possible, and excluded from water- or ethanol-based systems and from diagnostic or medical use.

• 3D Organoid–Fibroblast Models of PDAC Chemoresistance

  2026-08-19

  Schuth et al. developed a patient-matched three-dimensional co-culture system combining pancreatic ductal adenocarcinoma organoids with cancer-associated fibroblasts. The model revealed that fibroblasts increase organoid proliferation, reduce chemotherapy-induced cell death, and promote transcriptional programs associated with inflammation and epithelial-to-mesenchymal transition, providing a more physiologically informative platform for personalized drug-response research.

• VX-745: Practical p38α MAPK Inhibition

  2026-08-18

  VX-745 combines nanomolar p38α selectivity with practical workflows for cytokine, cancer, aging, and arthritis research. This guide connects pathway inhibition to phosphatase-aware assay design, helping researchers distinguish direct signaling effects from formulation, timing, and cell-context artifacts.

• Amyloid Beta-Peptide (1-40): Assay Workflows

  2026-08-18

  Build reproducible amyloid fibril formation and membrane-interaction assays with a defined human Aβ40 model. This guide combines practical handling of Amyloid Beta-Peptide (1-40) (human) with calcium-timing controls and surface-sensitive readouts inspired by recent spectroscopy research.

• Clathrin-Mediated Entry of Grass Carp Reovirus

  2026-08-17

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin- and pH-dependent clathrin-mediated pathway. The study also clarifies that amiloride did not inhibit viral entry under the tested conditions, an important negative result when interpreting ion-channel or endocytosis-focused experiments.

• Neticonazole Hydrochloride: Applied Research Guide

  2026-08-17

  Neticonazole Hydrochloride supports two distinct research workflows: fungal susceptibility testing and exploratory colorectal cancer studies. This guide connects practical assay design, formulation handling, exosome analysis, and the targeted oral delivery principles demonstrated in a colon cancer nanomedicine study.

• Chuanxiong Cortex and Pith in Coronary Heart Disease

  2026-08-16

  A 2023 study combined SPME-GC×GC-MS, network pharmacology, and molecular docking to distinguish the volatile chemistry and predicted coronary heart disease mechanisms of Chuanxiong cortex and pith. Its central contribution is a tissue-resolved framework for linking differential metabolites to candidate targets and pathways, while also highlighting the need for experimental validation beyond computational evidence.

• Bradykinin Workflows for Vascular Signaling

  2026-08-15

  Use Bradykinin as an acute, endothelium-dependent vasodilator probe to separate endothelial signaling, vascular permeability modulation, and smooth muscle responses. This workflow also shows how vascular assays can be paired cautiously with mitochondrial and inflammatory readouts inspired by recent diabetic cognitive dysfunction research.

• CAF EV lncRNA Drives PDAC Immune Evasion

  2026-08-14

  The reference study identifies CAF-derived extracellular vesicle RNA RP11-161H23.5 as a mediator of pancreatic ductal adenocarcinoma immune escape. It links this lncRNA to CNOT4-dependent shortening of the HLA-A mRNA poly(A) tail and evaluates engineered extracellular vesicles carrying siRNA as a potential intervention.

• Sulfaphenazole: CYP2C9 Assay Interpretation Guide

  2026-08-14

  Sulfaphenazole is a CYP2C9 inhibitor with value beyond enzyme inhibition. This guide explains how to interpret concentration, oxidative-stress, vascular, and antibacterial data without conflating mechanistic evidence with translational proof.

• Acetylcholine Chloride: Designing Causal Assays

  2026-08-13

  Acetylcholine Chloride can serve as a mechanistic calibration tool for studying gut–vagus–brain cholinergic signaling. This article explains how to use it to separate direct acetylcholine receptor activation from microbiota-mediated effects and improve assay interpretation.

• ML133 HCl: Designing Better Kir2.1 Assays

  2026-08-13

  ML133 HCl is a selective potassium channel inhibitor for dissecting Kir2.1-dependent potassium ion transport and pulmonary vascular remodeling. This guide translates published PASMC findings into practical assay-design decisions, including controls, pH considerations, endpoint selection, and compound handling.

• PDHA1 Succinylation and Immune Escape in CCA

  2026-08-12

  This Nature Communications study identifies PDHA1 succinylation as a metabolic-immune mechanism in cholangiocarcinoma. The modification increases alpha-ketoglutarate accumulation, suppresses macrophage antigen presentation through OXGR1-MAPK signaling, and provides a preclinical rationale for combining succinylation-axis inhibition with gemcitabine and cisplatin.

• Olsalazine Sodium: From LTB4 to Transport Assays

  2026-08-12

  Olsalazine Sodium is a mesalamine dimer that connects LTB4 chemotaxis biology with colorectal cancer and xenobiotic transport research. This evidence-led guide explains how to design better assays by separating anti-inflammatory activity, tumor phenotype, and compound disposition.

• S-Adenosylmethionine: Applied Methylation Workflows

  2026-08-11

  Build more controllable methylation assays with Ademetionine by pairing concentration titrations, stability-aware handling, and pathway-specific controls. This practical guide connects enzyme, epigenetic, metabolic, and neurobiology applications while separating bench evidence from clinical interpretation.

16258 records 1/1084 page Next 12345 下5页 Last page